Read More

US Stocks Mark 7th Week Of Gains, Nasdaq Moves Closer To All-Time Highs: What’s Driving Markets Friday?

U.S. stocks are poised to close their seventh consecutive week of gains, marking their longest winning streak since October 2017. In Friday’s session, the S&P 500 index hovered around the flatline at 1 p.m. in New York, while the Nasdaq 100 rose by 0.4%, getting closer to retesting their all-time highs.

BA

Read More

A 2024 Investor Guide To New York’s Cannabis Market Expansion: The MSO Wealth Roadmap

Considering the significant growth potential in New York's cannabis market and the strategic positioning of Multi-State Operators (MSOs) highlighted in Zuanic & Associate's latest report, how might investors capitalize on

CCHWF

Read More

FDA Approves Merck’s Drug Belzutifan For Type Of Advanced Kidney Cancer In Pretreated Cancer Patients

The FDA approved Merck & Co Inc's (NYSE: MRK) Welireg (belzutifan), an oral hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor, for adult patients with advanced renal cell carcinoma (RCC) following a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor and

MRK

Read More

US Stocks Eye 7-Day Winning Streak As Mortgage Rates Fall Below 7%, Yields Tumble: What’s Driving Markets Thursday?

It’s shaping up to be a positive Thursday on Wall Street, with risk sentiment remaining robust after the Federal Reserve effectively opened the door to rate cuts in 2024.

ALGN